ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Comparison of CKD-EPI, MDRD and Cockcroft-Gault to estimative baseline renal function in patients with head & neck thoracic cancers (2013)
Castria, T. B.; Bitton, R. C.; Amaral, A. A.; Lollo, J. G; Silva, V. T Costa e; Burdmann, Emmanuel de Almeida; Hoff, Paulo Marcelo Gehm; Castro Junior, G.
Source: European Journal of Cancer. Conference titles: European Cancer Congress 2013 Abstract Book. Unidade: FM
Subjects: NEFROPATIAS (ETIOLOGIA), NEOPLASIAS TORÁCICAS (RADIOGRAFIA;COMPLICAÇÕES), NEOPLASIAS DE CABEÇA E PESCOÇO (RADIOTERAPIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRIA, T. B. et al. Comparison of CKD-EPI, MDRD and Cockcroft-Gault to estimative baseline renal function in patients with head & neck thoracic cancers. European Journal of Cancer. Oxford: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529. Acesso em: 28 abr. 2026. , 2013
APA
Castria, T. B., Bitton, R. C., Amaral, A. A., Lollo, J. G., Silva, V. T. C. e, Burdmann, E. de A., et al. (2013). Comparison of CKD-EPI, MDRD and Cockcroft-Gault to estimative baseline renal function in patients with head & neck thoracic cancers. European Journal of Cancer. Oxford: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
NLM
Castria TB, Bitton RC, Amaral AA, Lollo JG, Silva VTC e, Burdmann E de A, Hoff PMG, Castro Junior G. Comparison of CKD-EPI, MDRD and Cockcroft-Gault to estimative baseline renal function in patients with head & neck thoracic cancers [Internet]. European Journal of Cancer. 2013 ; 49 S275.[citado 2026 abr. 28 ] Available from: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
Vancouver
Castria TB, Bitton RC, Amaral AA, Lollo JG, Silva VTC e, Burdmann E de A, Hoff PMG, Castro Junior G. Comparison of CKD-EPI, MDRD and Cockcroft-Gault to estimative baseline renal function in patients with head & neck thoracic cancers [Internet]. European Journal of Cancer. 2013 ; 49 S275.[citado 2026 abr. 28 ] Available from: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
Trabalho de evento-resumo periodico
Palliative chemotherapy in patients with malignant bowel obstruction (2013)
Muniz, D. Q.; Mak, M. P.; Bitton, R. C.; Takahasi, T. K.; Saragiotto, D. F.; Abdo, E.; Sabbaga, J.; Hoff, Paulo Marcelo Gehm
Source: European Journal of Cancer. Conference titles: European Cancer Congress 2013 Abstract Book. Unidade: FM
Subjects: NEOPLASIAS DO GENITAIS FEMININOS (CIRURGIA;TERAPIA), NEOPLASIAS DO SISTEMA DISGESTÓRIO, TERAPIAS COMPLEMENTARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MUNIZ, D. Q. et al. Palliative chemotherapy in patients with malignant bowel obstruction. European Journal of Cancer. Oxford: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529. Acesso em: 28 abr. 2026. , 2013
APA
Muniz, D. Q., Mak, M. P., Bitton, R. C., Takahasi, T. K., Saragiotto, D. F., Abdo, E., et al. (2013). Palliative chemotherapy in patients with malignant bowel obstruction. European Journal of Cancer. Oxford: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
NLM
Muniz DQ, Mak MP, Bitton RC, Takahasi TK, Saragiotto DF, Abdo E, Sabbaga J, Hoff PMG. Palliative chemotherapy in patients with malignant bowel obstruction [Internet]. European Journal of Cancer. 2013 ; 49 S281.[citado 2026 abr. 28 ] Available from: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
Vancouver
Muniz DQ, Mak MP, Bitton RC, Takahasi TK, Saragiotto DF, Abdo E, Sabbaga J, Hoff PMG. Palliative chemotherapy in patients with malignant bowel obstruction [Internet]. European Journal of Cancer. 2013 ; 49 S281.[citado 2026 abr. 28 ] Available from: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
Trabalho de evento-resumo periodico
Predicting adverse outcomes after cisplatin administration in head & neack and thoracic cancer (2013)
Bitton, R. C.; Castria, T. B.; Amaral, A. A.; Lollo, J. G; Silva, V. T Costa e; Burdmann, Emmanuel de Almeida; Hoff, Paulo Marcelo Gehm; Castro Junior, G.
Source: European Journal of Cancer. Conference titles: European Cancer Congress 2013 Abstract Book. Unidade: FM
Subjects: INSUFICÊNCIA RENAL (ETIOLOGIA), NEOPLASIAS TORÁCICAS (QUIMIOTERAPIA), NEOPLASIAS DE CABEÇA E PESCOÇO (QUIMIOTERAPIA;COMPLICAÇÕES)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BITTON, R. C. et al. Predicting adverse outcomes after cisplatin administration in head & neack and thoracic cancer. European Journal of Cancer. Oxford: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529. Acesso em: 28 abr. 2026. , 2013
APA
Bitton, R. C., Castria, T. B., Amaral, A. A., Lollo, J. G., Silva, V. T. C. e, Burdmann, E. de A., et al. (2013). Predicting adverse outcomes after cisplatin administration in head & neack and thoracic cancer. European Journal of Cancer. Oxford: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
NLM
Bitton RC, Castria TB, Amaral AA, Lollo JG, Silva VTC e, Burdmann E de A, Hoff PMG, Castro Junior G. Predicting adverse outcomes after cisplatin administration in head & neack and thoracic cancer [Internet]. European Journal of Cancer. 2013 ; 49 S279.[citado 2026 abr. 28 ] Available from: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
Vancouver
Bitton RC, Castria TB, Amaral AA, Lollo JG, Silva VTC e, Burdmann E de A, Hoff PMG, Castro Junior G. Predicting adverse outcomes after cisplatin administration in head & neack and thoracic cancer [Internet]. European Journal of Cancer. 2013 ; 49 S279.[citado 2026 abr. 28 ] Available from: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529

USP Schools

ReP

Filtros

Authors

Subjects